The U.S. Food and Drug Administration said on Friday it has approved AstraZeneca's nasal spray flu vaccine for self-administration, making it the first of its kind.

1238317363

Reuters

United Kingdom

US FDA approves AstraZeneca's self-administered nasal spray flu vaccine

Ad Fontes Media

All Sides

Media Bias/Fact Check

The Woodbridge Company

The US Food and Drug Administration on Friday approved the first flu vaccine that does not have to be administered by a health care provider, but it won’t be available in time for this respiratory virus season.

Warner Bros. Discovery

Atlanta

Fulton County

Georgia

United States

FDA approves first flu vaccine that can be self-administered at home

AstraZeneca says the spray could be available &quot;as soon as next flu season.&quot;

CBS News

National Amusements

Michael Redstone

FDA approves first self-administered flu vaccine spray

The Food and Drug Administration (FDA) announced Friday it has approved the first flu vaccine that can be self-administered, with this version being a nasal spray as opposed to an injection. The vaccine FluMist, manufactured by MedImmune, which was acquired by AstraZeneca in 2007, was first approved by the FDA in 2003 for individuals between…

The Hill

Nexstar Media Group

Washington

District of Columbia

FDA approves first self-administered flu vaccine

Anyone over 18 will be authorised to administer the vaccine to themselves or another person. Read more at straitstimes.com.

The Straits Times

Singapore Press Holdings

Singapore

No doctor necessary: US okays nasal spray flu vaccine for self-use

The U.S. Food and Drug Administration (FDA) has green-lit AstraZeneca’s nasal flu vaccine that can be self-administered without a health care provider. 
On Friday, the FDA announced that it approved FluMist for the prevention of influenza subtypes A and B in individuals aged 2 to 49 years old.
FluMist is a nasal spray and has been used “safely and effectively for many years,” having initially been approved in 2003 for people aged 5 to 49, the FD…

The Epoch Times

Epoch Media Group

New York

FDA Approves Self-Administered Nasal Flu Vaccine

The FluMist vaccine, produced by AstraZeneca, had already been authorized several years ago by the North American Medicines Agency (FDA) for people between the ages of two and 49. Minors should not manage it alone, but parents or caregivers can do so. This is a “new option to receive a safe and effective vaccine against seasonal influenza, potentially more practical, more flexible, and more accessible to individuals and families,” said Peter Mar…

A vacina FluMist, produzida pela AstraZeneca, já tinha sido autorizada há vários anos pela agência norte-americana do medicamento (FDA, na sigla em inglês) para pessoas com idades entre os dois e os 49 anos.   Os menores não devem administrá-la sozinhos, mas os pais ou cuidadores podem fazê-lo. Esta é uma "nova opção para receber uma vacina segura e eficaz contra a gripe sazonal, potencialmente mais prática, mais flexível, e mais acessível para …

EUA autorizam vacina contra a gripe para autoadministração

Noticias ao Minuto

Portugal

US authorizes flu vaccine for self-administration

The nasal spray option could encourage more people who have fears of doctors or needles to inoculate themselves against the flu.

National Public Radio, Inc

No needles required: The FDA approves an at-home flu vaccine

The first flu vaccine to be administered by yourself without the help of a health professional, a nasal spray, will be available this fall in the United States.

Le premier vaccin contre la grippe à s’administrer soi-même sans l’aide d’un professionnel de santé, en spray nasal, sera disponible cet automne aux États-Unis.

États-Unis : le premier vaccin contre la grippe à s’administrer soi-même autorisé

Le Parisien

LVMH

Paris

Île-de-France

France

United States: the first self-administered flu vaccine authorized

WASHINGTON, Sept 21 — No doctor? No problem. In a first, the US Food and Drug Administration yesterday approved a nasal spray flu vaccine for self-administration. Starting next fall, AstraZeneca’s FluMist, which was authorised in 2003 to be administered by a health care provider, will be available to ordinary Americans through an online pharmacy. The needle-free spray would be shipped following a screening assessment. “Today’s approval of the fi…

Malay Mail

Dato’ Siew Ka Wei

Selangor

Malaysia

Influenza

AstraZeneca

Health

Vaccines

Flu Season

Medical

KCRA 3

abc 7 Chicago

abc 7 LA

WCVB

Medical Xpress

WLWT

WMUR

abc 7 News

abc30 News

WLKY

WESH

Koco News5

WDSU

KETV

WYFF

WTAE

Sud Ouest

KCCI

EL ESPAÑOL

KMBC

TVA Nouvelles

WISN

WBAL-TV

Spectrum Local News

WPTZ

WMTW

France Info

WVTM

WAPT

KRQE News 13

WGN 9

KOAT

KWWL

Fox8

KDVR

WPBF

Salon

WGAL

U.S. News

WXII

KFOR-TV

KSBW

WSPA

WJCL

FOX 5 San Diego

WOWK

KHBS

Upstract

WATE

Scripps News

abc12/WJRT

WHO-DT

HealthDay

MOR-TV

CBS58

Your Blog Domain

KPBS

PHL17

STAT

WNTZ FOX 48

MedPage Today

SecularTimes

AlKhaleej Today

EuropaWire.eu

Macau Business

Kingsport Times-News

thepublicsradio.org

Dataemia

Endpoints News

Pharmacy Times

wbiw.com

contagionlive.com

Market Research Telecast

Managed Healthcare Executive

drugtopics.com

kios.org

contemporarypediatrics.com

Healthcare Packaging

US FDA approves AstraZeneca's self-administered nasal spray flu vaccine

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics